Publication | Closed Access
Phase II investigation of docetaxel in pediatric patients with recurrent solid tumors
61
Citations
17
References
2006
Year
Docetaxel demonstrated activity in patients with recurrent Ewing sarcoma but was found to be ineffective for treating the other types of recurrent solid tumors that were studied.
| Year | Citations | |
|---|---|---|
Page 1
Page 1